FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo.

Source:http://linkedlifedata.com/resource/pubmed/id/11497281

Download in:

View as

General Info

PMID
11497281